WallStreetZenWallStreetZen

NASDAQ: MRKR
Marker Therapeutics Inc Stock Ownership - Who owns Marker Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Marker Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ElmsDirector2024-12-2311,085$3.20
$35.47kBuy
New Enterprise Associates 16 LP10% Owner2024-12-23554,250$3.20
$1.77MBuy

1 of 1

MRKR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRKR insiders and whales buy or sell their stock.

MRKR Shareholders

What type of owners hold Marker Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Carmen Chang94.69%10,714,285$15.00MInsider
Anthony A. Florence Jr.94.69%10,714,285$15.00MInsider
Paul Edward Walker94.69%10,714,285$15.00MInsider
Ali Behbahani94.69%10,714,285$15.00MInsider
Joshua Makower94.69%10,714,285$15.00MInsider
Mohamad Makhzoumi94.69%10,714,285$15.00MInsider
Forest Baskett94.69%10,714,285$15.00MInsider
Scott D. Sandell94.69%10,714,285$15.00MInsider
Peter W. Sonsini94.69%10,714,285$15.00MInsider
John Robert Wilson69.04%7,812,008$10.94MInsider

1 of 3

MRKR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRKR2.89%97.11%Net Buying
ALLR0.61%13.17%Net Buying
NEUP2.40%97.60%
KAPA9.36%40.23%Net Buying
EDSA23.70%76.30%Net Buying
View Top Biotech Stocks

Marker Therapeutics Stock Ownership FAQ

Who owns Marker Therapeutics?

Marker Therapeutics (NASDAQ: MRKR) is owned by 36.21% institutional shareholders, 1,217.46% Marker Therapeutics insiders, and 0.00% retail investors. Carmen Chang is the largest individual Marker Therapeutics shareholder, owning 10.71M shares representing 94.69% of the company. Carmen Chang's Marker Therapeutics shares are currently valued at $14.46M.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.